Certain tumors shed neoplastic cells into the blood before the primary tumor growth can be detected in the body. It has been shown recently that epithelial cells from the tumor can be detected in the blood at concentrations as low as 1 cell per ml of blood, and that the presence of rare cancer cells in blood has an important diagnostic value. The current screening methods are limited by relatively low speed of Fluorescent Activated Cell Scanning. (FACS),and complexity of preenrichment methods. The overall objective of this proposal is to develop a high-throughput, immunomagnetically based cell separating system to recover as many rare cancer cells in human blood as possible, for further molecular analysis (such as PCR, biological assays and other).
The specific aims are as follows. First: the primary separation will be conduced using a novel continuos, flow-through immunomagnetic unit developed in our laboratories. Continuos units are intrinsically more efficient with respect to high throughput. We propose to develop experimental and theoretical basis for the next generation system which will sort cells at a rate of 10/7 cells/s, and allow a non- destructive screening of an entire volume of blood product used for cancer cell therapy ( typically 0.5 to 1.0 liters) in a short period of time (<1hour). Second: the continuos cell separation process can be staged, unlike the currently used batch systems. We propose to develop experimental and theoretical basis for the continuos staged separation process which will further increase the purity and decrease the volume of the cell product, and thus increase the rate of success of analysis downstream of the cell separation step. Third: the current cell labeling procedure may require modifications and optimization for the best performance in targeting and isolating rare cancer cells. We propose to screen available monoclonal antibodies and colloidal magnetic labels for the highest sensitivity and specificity in targeting rare cancer cells using unique Cell Tracking Velocimetry instrument developed in our laboratories. In summary, this proposal focuses on the """"""""front-end"""""""" of cancer screening namely a high-throughoutput device to rapidly isolate and concentrate rare cancer cells form large numbers of cells. This proposal is responsive to PAR-98-067, Innovative Technologies for the Molecular analysis of Cancer, and we believe it addresses the second objective of the PAR, namely """"""""novel technologies that will allow high- throughput analysis of genetic alterations, expression of genome products, and monitoring of signal transduction pathways to cancer.""""""""

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants Phase II (R33)
Project #
5R33CA081662-03
Application #
6377239
Study Section
Special Emphasis Panel (ZCA1-SRRB-C (J2))
Project Start
1999-04-06
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2003-03-31
Support Year
3
Fiscal Year
2001
Total Cost
$346,760
Indirect Cost
Name
Ohio State University
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Wu, Yongqi; Deighan, Clayton J; Miller, Brandon L et al. (2013) Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology. Methods 64:169-82
Zborowski, Maciej; Chalmers, Jeffrey J (2011) Rare cell separation and analysis by magnetic sorting. Anal Chem 83:8050-6
Jatana, Kris R; Lang, Jas C; Chalmers, Jeffrey J (2011) Identification of circulating tumor cells: a prognostic marker in squamous cell carcinoma of the head and neck? Future Oncol 7:481-4
Yang, Liying; Lang, James C; Balasubramanian, Priya et al. (2009) Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol Bioeng 102:521-34
Tong, Xiaodong; Yang, Liying; Lang, James Campbell et al. (2007) Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytometry B Clin Cytom 72:310-23
Zhang, Huading; Williams, P Stephen; Zborowski, Maciej et al. (2006) Binding affinities/avidities of antibody-antigen interactions: quantification and scale-up implications. Biotechnol Bioeng 95:812-29
Zhang, Huading; Moore, Lee R; Zborowski, Maciej et al. (2005) Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions. Analyst 130:514-27
Mollet, Mike; Ma, Ningning; Zhao, Yang et al. (2004) Bioprocess equipment: characterization of energy dissipation rate and its potential to damage cells. Biotechnol Prog 20:1437-48
Lara, Oscar; Tong, Xiaodong; Zborowski, Maciej et al. (2004) Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. Exp Hematol 32:891-904
Williams, P Stephen; Decker, Keith; Nakamura, Masayuki et al. (2003) Splitter imperfections in annular split-flow thin separation channels: experimental study of nonspecific crossover. Anal Chem 75:6687-95

Showing the most recent 10 out of 23 publications